Unlocks Efficiency Gains with High-Speed Search, Easy Metadata Tagging, and On-Platform AI Analysis NEW YORK--(BUSINESS WIRE)--HistoWiz, a leader in digital pathology services, introduces ...
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering ...
To improve diagnosis for patients with complex metastatic cancers, especially those in low-resource settings, researchers have developed an artificial intelligence (AI) system that uses routinely ...
Bethesda, MD-The American Association of Anatomists (AAA) launches their first-ever Virtual Microscopy Database available to educators and researchers worldwide. The Virtual Microscopy Database (VMD) ...
This diagnostic study recruited 67 patients with I-III GEJ adenocarcinoma from the multicentric nonrandomized MEMORI trial including three German university hospitals TUM (University Hospital Rechts ...
NeoRad(Low): A phase 2 trial of neoadjuvant (NA) ipilimumab + nivolumab (ipi+nivo) with low dose stereotactic body radiation therapy (SBRT) as an immune stimulant in patients with resectable stage ...
High-throughput, mid capacity LH210 expands the VISQUE DPS lineup with fast scanning, optimized data size, and scalable digital pathology workflow Like the LH510 in the VISQUE DPS lineup, the LH210 ...
In 1 to 2 percent of cancer cases, the primary site of tumor origin cannot be determined. Because many modern cancer therapeutics target primary tumors, the prognosis for a cancer of unknown primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results